Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 3, 2007, Pages 371-376

  Chen Scarabelli, Carol ^a   Scarabelli, Tiziano M ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Implantable cardioverter defibrillators; Mortality; Renal insufficiency

Indexed keywords

AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEFIBRILLATOR; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RECIPIENT; RETROSPECTIVE STUDY;

AGED; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MICHIGAN; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33947275802     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00677.x     Document Type: Article

References (20)

1. McCullough PA, Sandberg KR. Chronic kidney disease and sudden death: Strategies for prevention. Blood Purif 2004; 22:136-142.
2. Das M, Aronow WS, McClung JA, Belkin RN. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency. Cardiol Rev 2006; 14:14-17.
3. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005; 26:11-17.
4. Raine AE, Margreiter R, Brunner FP, Enrich JH, Geerlings W, Lándais P, Loirat C, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl. 2):7-35.
5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
6. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004; 11:199-204.
7. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68:818-825.
8. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, et al. Multicenter automatic defibrillator implantation trial-II investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006; 98:485-490.
9. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137:563-570.
10. Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J 2004; 147:623-629.
11. Soman SS, Sandberg KR, Borzak S, Hudson MP, Yee J, McCullough PA. The independent association of renal dysfunction and arrhythmias in critically ill patients. Chest 2002; 122:669-677.
12. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, Borzak S. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000; 36:679-684.
13. Aronow WS, Ahn C, Mercando AD, Epstein S. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000; 86:1142-1143, A9.
14. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004; 43:699-706.
15. Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: A wake-up call. J Am Soc Nephrol 2004; 15:524-537.
16. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307:205-211.
17. Maurice JP, Shah AS, Kypson AP, Hata JA, White DC, Glower DD, Koch WJ. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol 1999; 276:H1853-H1860.
18. Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LM. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 2005; 46:426-432.
19. Gondo N, Kumagai K, Nakashima H, Saku K. Angiotensin II provokes cesium-induced ventricular tachyarrhythmias. Cardiovasc Res 2001; 49:381-390.
20. Domenighetti AA, Boixel C, Cefai D, Abriel H, Pedrazzini T. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol 2006; 42:63-70.